Bhaskar Chaudhuri - Net Worth and Insider Trading

Bhaskar Chaudhuri Net Worth

The estimated net worth of Bhaskar Chaudhuri is at least $8 Million dollars as of 2024-05-26. Bhaskar Chaudhuri is the Director of Arcutis Biotherapeutics Inc and owns about 891,372 shares of Arcutis Biotherapeutics Inc (ARQT) stock worth over $8 Million. Bhaskar Chaudhuri is the President of Bausch Health Companies Inc and owns about 10,283 shares of Bausch Health Companies Inc (BHC) stock worth over $65,400. Bhaskar Chaudhuri is also the Director of Teligent Inc and owns about 1,000 shares of Teligent Inc (TLGTQ) stock worth over $0. Details can be seen in Bhaskar Chaudhuri's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Bhaskar Chaudhuri has not made any transactions after 2021-06-25 and currently still holds the listed stock(s).

Transaction Summary of Bhaskar Chaudhuri

To

Bhaskar Chaudhuri Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Bhaskar Chaudhuri owns 4 companies in total, including Tarsus Pharmaceuticals Inc (TARS) , Arcutis Biotherapeutics Inc (ARQT) , and Teligent Inc (TLGTQ) among others .

Click here to see the complete history of Bhaskar Chaudhuri’s form 4 insider trades.

Insider Ownership Summary of Bhaskar Chaudhuri

Ticker Comapny Transaction Date Type of Owner
TARS Tarsus Pharmaceuticals Inc 2020-10-15 director
ARQT Arcutis Biotherapeutics Inc 2021-06-25 director
TLGTQ Teligent Inc 2021-01-04 director
2018-11-27 director

Bhaskar Chaudhuri Latest Holdings Summary

Bhaskar Chaudhuri currently owns a total of 3 stocks. Among these stocks, Bhaskar Chaudhuri owns 891,372 shares of Arcutis Biotherapeutics Inc (ARQT) as of June 25, 2021, with a value of $8 Million and a weighting of 99.21%. Bhaskar Chaudhuri owns 10,283 shares of Bausch Health Companies Inc (BHC) as of November 20, 2009, with a value of $65,400 and a weighting of 0.79%. Bhaskar Chaudhuri also owns 1,000 shares of Teligent Inc (TLGTQ) as of June 3, 2019, with a value of $0 and a weighting of 0%.

Latest Holdings of Bhaskar Chaudhuri

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
ARQT Arcutis Biotherapeutics Inc 2021-06-25 891,372 9.16 8,164,968
BHC Bausch Health Companies Inc 2009-11-20 10,283 6.36 65,400
TLGTQ Teligent Inc 2019-06-03 1,000 0.00 0

Holding Weightings of Bhaskar Chaudhuri


Bhaskar Chaudhuri Form 4 Trading Tracker

According to the SEC Form 4 filings, Bhaskar Chaudhuri has made a total of 7 transactions in Arcutis Biotherapeutics Inc (ARQT) over the past 5 years, including 0 buys and 7 sells. The most-recent trade in Arcutis Biotherapeutics Inc is the sale of 7,484 shares on June 25, 2021, which brought Bhaskar Chaudhuri around $205,810.

According to the SEC Form 4 filings, Bhaskar Chaudhuri has made a total of 0 transactions in Bausch Health Companies Inc (BHC) over the past 5 years. The most-recent trade in Bausch Health Companies Inc is the acquisition of 3,000 shares on November 20, 2009, which cost Bhaskar Chaudhuri around $99,930.

According to the SEC Form 4 filings, Bhaskar Chaudhuri has made a total of 1 transactions in Teligent Inc (TLGTQ) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Teligent Inc is the acquisition of 1,000 shares on June 3, 2019, which cost Bhaskar Chaudhuri around $7,000.

Insider Trading History of Bhaskar Chaudhuri

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Bhaskar Chaudhuri Trading Performance

GuruFocus tracks the stock performance after each of Bhaskar Chaudhuri's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Bhaskar Chaudhuri is 15.08%. GuruFocus also compares Bhaskar Chaudhuri's trading performance to market benchmark return within the same time period. The performance of stocks bought by Bhaskar Chaudhuri within 3 months outperforms 9 times out of 11 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Bhaskar Chaudhuri's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Bhaskar Chaudhuri

Average Return

Average return per transaction

Outperforming Transactions

10 out of 11 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 5.17
Relative Return to S&P 500(%) 1.79

Bhaskar Chaudhuri Ownership Network

Ownership Network List of Bhaskar Chaudhuri

No Data

Ownership Network Relation of Bhaskar Chaudhuri


Bhaskar Chaudhuri Owned Company Details

What does Tarsus Pharmaceuticals Inc do?

Who are the key executives at Tarsus Pharmaceuticals Inc?

Bhaskar Chaudhuri is the director of Tarsus Pharmaceuticals Inc. Other key executives at Tarsus Pharmaceuticals Inc include Chief Human Resources Officer Dianne C. Whitfield , director & 10 percent owner & President and CEO Bobak R. Azamian , and Chief Operating Officer Seshadri Neervannan .

Tarsus Pharmaceuticals Inc (TARS) Insider Trades Summary

Over the past 18 months, Bhaskar Chaudhuri made no insider transaction in Tarsus Pharmaceuticals Inc (TARS). Other recent insider transactions involving Tarsus Pharmaceuticals Inc (TARS) include a net sale of 329,867 shares made by Bobak R. Azamian , a net sale of 26,966 shares made by Leonard M. Greenstein , and a net sale of 18,404 shares made by Bryan Wahl .

In summary, during the past 3 months, insiders sold 28,810 shares of Tarsus Pharmaceuticals Inc (TARS) in total and bought 0 shares, with a net sale of 28,810 shares. During the past 18 months, 421,985 shares of Tarsus Pharmaceuticals Inc (TARS) were sold and 10,506 shares were bought by its insiders, resulting in a net sale of 411,479 shares.

Tarsus Pharmaceuticals Inc (TARS)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Tarsus Pharmaceuticals Inc Insider Transactions

No Available Data

Bhaskar Chaudhuri Mailing Address

Above is the net worth, insider trading, and ownership report for Bhaskar Chaudhuri. You might contact Bhaskar Chaudhuri via mailing address: One Enterprise, Aliso Viejo Ca 92656.

Discussions on Bhaskar Chaudhuri

No discussions yet.